Variational AI applies its 𝐄𝐧𝐤𝐢™ generative AI platform to design novel PRMT6 inhibitor scaffolds and discover lead candidates. To ensure rapid execution and reduce downstream attrition, the ...

KYIV, UKRAINE, January 16, 2026 /EINPresswire.com/ — ABX-CRO and Enamine initiated their cooperation in 2024. Since then, Enamine supports ABX-CRO with its ...

KYIV, Ukraine & SANKT AUGUSTIN, Germany--(BUSINESS WIRE)--The two leading experts in the exploration of ultra-large make-on-demand chemical spaces join forces to spark a new era of drug discovery.

Kyiv, Ukraine and Salt Lake City, UT, April 09, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced ...

Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate 2,000 new compounds generated ...

KYIV, Ukraine--(BUSINESS WIRE)--Enamine Ltd., a provider of drug discovery services empowered with the world’s largest collections of building blocks, fragments, and screening compounds, gave an ...

Enamine’s Target-Agnostic Expertise in Biology, Drug Design, and Medicinal Chemistry Advances EMUNO Therapeutics Pipeline KYIV, UKRAINE, January 22, 2026 ...

Peapod Bio Inc., announced a strategic collaboration with Enamine, a global supplier of high-quality small molecule libraries. This partnership enables Peapod Bio to offer its clients fully integrated ...

Enamine’s agile IDD Platform of Computer-aided Drug Design (CADD), together with AI/ML approaches, innovative medicinal chemistry, and preclinical biology, including its capabilities in guiding ...

Enamine, a leading chemistry and R&D services company, today announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of a ...